Advertisement

Topics

Alert on adverse events risk in Abbott's Absorb BVS released by FDA

07:02 EDT 20 Mar 2017 | SmartBrief

The FDA has issued a letter alerting health care providers about the increased rates of major adverse cardiac events and sten -More

Original Article: Alert on adverse events risk in Abbott's Absorb BVS released by FDA

NEXT ARTICLE

More From BioPortfolio on "Alert on adverse events risk in Abbott's Absorb BVS released by FDA"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...